Effects of Retatrutide on Comorbidities and Cardiometabolic Markers In the knee osteoarthritis basket, retatrutide resulted in a WOMAC pain score reduction exceeding the four-point clinically significant threshold, translating to up to more than a 70% decrease in pain
Genetic variants in the GLP1R gene (e.g., rs6923761), GIPR receptor (rs1800437), FTO (rs9939609), and MC4R (rs17782313) influence appetite signaling, energy expenditure, and medication responsiveness
This combination is essential to achieve and maintain long-term weight management goals
The FDA doesnt review these versions for safety, effectiveness, or quality, however
As the clinical landscape for GLP-1s continues to evolve, were committed to supporting plan sponsors with evidence-based, clinically appropriate coverage, cost, and care solutions that can help control spend without compromising health outcomes.
& Millet, J